Stock 4TMO THERMO FISHER SCIENTIFIC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Thermo Fisher Scientific Inc. Borsa Italiana

Equities

4TMO

US8835561023

Real-time Estimate Tradegate
Other stock markets
 05:17:47 2024-07-12 am EDT 		5-day change 1st Jan Change
498.4 EUR -0.88% Intraday chart for Thermo Fisher Scientific Inc. +2.39% +4.34%
Jul. 11 Thermo Fisher Scientific Keeps Quarterly Cash Dividend at $0.39 Per Share, Payable Oct. 15 to Holders as of Sept. 13 MT
Jul. 11 Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on October 15, 2024 CI

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's high margin levels account for strong profits.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company is in debt and has limited leeway for investment
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 33.86 times its estimated earnings per share for the ongoing year.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The company is highly valued given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
THERMO FISHER SCIENTIFIC INC. Stock Thermo Fisher Scientific Inc.
+4.34% 207B -
DANAHER CORPORATION Stock Danaher Corporation
+6.45% 182B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+31.46% 157B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+33.00% 113B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+4.87% 66.91B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+21.77% 55.95B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-2.92% 47.01B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-5.91% 38.17B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+3.39% 36.49B -
RESMED, INC. Stock ResMed, Inc.
+16.14% 29.35B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. TMO Stock
  4. 4TMO Stock
  5. Ratings Thermo Fisher Scientific Inc.